BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 15222122)

  • 1. [Successful induction and complete improvement of myelofibrosis and erythema nosodum with cladribine in a case of hairy cell leukemia].
    Araki H; Matsunaga T; Murase K; Kuroda H; Kuribayashi K; Terui T; Niitsu Y
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):965-9. PubMed ID: 15222122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide.
    Strupp C; Fenk R; Kündgen A; Gattermann N; Haas R; Germing U
    Leuk Res; 2005 Aug; 29(8):967-9. PubMed ID: 15978949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Successful use of cladribine in the treatment of an elderly woman with typical hairy cell leukemia].
    Terasaki Y; Okumura H; Hirose A; Ishiura Y; Yokawa S; Saito K; Nakao S
    Gan To Kagaku Ryoho; 2007 Nov; 34(11):1885-8. PubMed ID: 18030031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 2-chlorodeoxyadenosine therapy on bone marrow fibrosis in hairy cell leukemia.
    Dedic K; Zák P
    Neoplasma; 2004; 51(1):56-8. PubMed ID: 15004661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hairy cell leukemia, Japanese variant, successfully treated with cladribine].
    Miyazaki M; Taguchi A; Sakuragi S; Mitani N; Matsuda K; Shinohara K
    Rinsho Ketsueki; 2004 May; 45(5):405-7. PubMed ID: 15199752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful treatment with cladribine for hypoplastic hairy cell leukemia after long-term neutropenia].
    Sakai R; Yamazaki E; Sakamoto H; Kanamori H; Ishigatsubo Y
    Rinsho Ketsueki; 2005 Nov; 46(11):1187-90. PubMed ID: 16440801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia.
    Yang MH; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 2001 Jan; 64(1):54-8. PubMed ID: 11310372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone marrow changes in patients with hairy cell leukemia after 2-chlorodeoxyadenosine treatment].
    Urasiński I; Zdziarska B; Krygier-Stojałowska A
    Acta Haematol Pol; 1996; 27(1):49-55. PubMed ID: 8629443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monitoring minimal residual disease in patients with hairy cell leukemia in complete remission after treatment with 2-chlorodioxyadenosine].
    Zák P; Chrobák L; Dĕdic K; Podzimek K
    Vnitr Lek; 2000 Oct; 46(10):697-703. PubMed ID: 11344629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine.
    Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J
    Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of hairy cell leukemia in a patient with antiphospholipid syndrome.
    Diz-Kucukkaya R; Dincol G; Kamali S; Kural F; Inanc M
    Lupus; 2007; 16(4):286-8. PubMed ID: 17439936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hairy cell leukemia: an elusive but treatable disease.
    Wanko SO; de Castro C
    Oncologist; 2006; 11(7):780-9. PubMed ID: 16880237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of hairy cell leukemia with cladribine].
    Aurer I; Mitrović Z; Kovacević-Metelko J; Radman I; Basić-Kinda S; Gjadrov-Kuvezdić K; Jakić-Razumović J; Dubravcić K; Ries S; Nola M; Zupancic-Salek S; Labar B
    Lijec Vjesn; 2007; 129(3-4):80-3. PubMed ID: 17557550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hairy cell leukemia--a potentially curable malignancy. Selected aspects of purine analog therapy].
    Rucińska M; Machaczka M; Załuska A; Skotnicki AB
    Przegl Lek; 1998; 55(7-8):400-6. PubMed ID: 10021885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hairy cell leukemia successfully treated with deoxycoformycin].
    Matsuda A; Jinnai I; Mizuno H; Sakata T; Kusumoto S; Kayano H; Takeuchi H; Bessho M; Saito M; Katayama I
    Rinsho Ketsueki; 1992 Nov; 33(11):1685-90. PubMed ID: 1469784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
    Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
    Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hairy-cell leukemia: a rare blood disorder in Asia.
    Josephine FP; Nissapatorn V
    Southeast Asian J Trop Med Public Health; 2006; 37 Suppl 3():190-4. PubMed ID: 17547079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Successful treatment of hairy cell leukemia with pentostatin].
    Fujita H; Koharazawa H; Nishida H; Terada S; Morishita T; Kuroyama Y; Ohata M; Ishigatsubo Y
    Rinsho Ketsueki; 2001 Jul; 42(7):537-42. PubMed ID: 11524843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [50-year-old man with weight loss and splenomegaly].
    Austein T; Schmitt A
    Dtsch Med Wochenschr; 2009 Feb; 134(6):251-2. PubMed ID: 19180417
    [No Abstract]   [Full Text] [Related]  

  • 20. [Bone marrow fibrosis during therapy of hairy cell leukemia].
    Dĕdic K; Zák P
    Cesk Patol; 2004 Jan; 40(1):22-4. PubMed ID: 15035057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.